nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—CYP2C8—Paclitaxel—ovarian cancer	0.0223	0.19	CbGbCtD
Mirtazapine—CYP2D6—Vinorelbine—ovarian cancer	0.0203	0.172	CbGbCtD
Mirtazapine—CYP3A4—Topotecan—ovarian cancer	0.0183	0.156	CbGbCtD
Mirtazapine—CYP2C9—Paclitaxel—ovarian cancer	0.0156	0.133	CbGbCtD
Mirtazapine—CYP3A4—Vinorelbine—ovarian cancer	0.0129	0.11	CbGbCtD
Mirtazapine—HTR7—vein—ovarian cancer	0.0123	0.106	CbGeAlD
Mirtazapine—CYP3A4—Paclitaxel—ovarian cancer	0.00905	0.0771	CbGbCtD
Mirtazapine—CYP2D6—Doxorubicin—ovarian cancer	0.00767	0.0653	CbGbCtD
Mirtazapine—HTR2A—vein—ovarian cancer	0.00767	0.0663	CbGeAlD
Mirtazapine—CYP3A4—Docetaxel—ovarian cancer	0.00654	0.0557	CbGbCtD
Mirtazapine—CYP3A4—Doxorubicin—ovarian cancer	0.00488	0.0415	CbGbCtD
Mirtazapine—DRD4—testis—ovarian cancer	0.00362	0.0313	CbGeAlD
Mirtazapine—HTR2B—myometrium—ovarian cancer	0.00282	0.0244	CbGeAlD
Mirtazapine—OPRK1—female reproductive system—ovarian cancer	0.00281	0.0243	CbGeAlD
Mirtazapine—ADRA2C—myometrium—ovarian cancer	0.00222	0.0192	CbGeAlD
Mirtazapine—HTR2B—uterine cervix—ovarian cancer	0.0022	0.019	CbGeAlD
Mirtazapine—HTR2B—decidua—ovarian cancer	0.00209	0.0181	CbGeAlD
Mirtazapine—HTR2B—endometrium—ovarian cancer	0.00199	0.0172	CbGeAlD
Mirtazapine—HTR7—epithelium—ovarian cancer	0.0019	0.0164	CbGeAlD
Mirtazapine—SLC6A2—decidua—ovarian cancer	0.00186	0.0161	CbGeAlD
Mirtazapine—HTR2B—uterus—ovarian cancer	0.00183	0.0159	CbGeAlD
Mirtazapine—ADRA1A—epithelium—ovarian cancer	0.00183	0.0158	CbGeAlD
Mirtazapine—HRH1—myometrium—ovarian cancer	0.00181	0.0156	CbGeAlD
Mirtazapine—ADRA2A—myometrium—ovarian cancer	0.00177	0.0154	CbGeAlD
Mirtazapine—HTR2C—female reproductive system—ovarian cancer	0.00175	0.0152	CbGeAlD
Mirtazapine—ADRA2C—uterine cervix—ovarian cancer	0.00173	0.015	CbGeAlD
Mirtazapine—ADRB1—female reproductive system—ovarian cancer	0.00172	0.0149	CbGeAlD
Mirtazapine—SLC6A4—female reproductive system—ovarian cancer	0.00166	0.0144	CbGeAlD
Mirtazapine—ADRA2C—decidua—ovarian cancer	0.00165	0.0143	CbGeAlD
Mirtazapine—HTR2B—female reproductive system—ovarian cancer	0.00165	0.0143	CbGeAlD
Mirtazapine—SLC6A2—gonad—ovarian cancer	0.00164	0.0142	CbGeAlD
Mirtazapine—HTR7—gonad—ovarian cancer	0.00158	0.0137	CbGeAlD
Mirtazapine—ADRA2C—endometrium—ovarian cancer	0.00156	0.0135	CbGeAlD
Mirtazapine—HTR2B—vagina—ovarian cancer	0.00149	0.0129	CbGeAlD
Mirtazapine—SLC6A3—testis—ovarian cancer	0.00146	0.0127	CbGeAlD
Mirtazapine—SLC6A2—female reproductive system—ovarian cancer	0.00146	0.0127	CbGeAlD
Mirtazapine—CYP2C8—endometrium—ovarian cancer	0.00145	0.0126	CbGeAlD
Mirtazapine—HTR2A—embryo—ovarian cancer	0.00145	0.0126	CbGeAlD
Mirtazapine—ADRA2C—uterus—ovarian cancer	0.00144	0.0125	CbGeAlD
Mirtazapine—HRH1—epithelium—ovarian cancer	0.00142	0.0123	CbGeAlD
Mirtazapine—HTR7—female reproductive system—ovarian cancer	0.00141	0.0122	CbGeAlD
Mirtazapine—HRH1—uterine cervix—ovarian cancer	0.00141	0.0122	CbGeAlD
Mirtazapine—ADRA2A—uterine cervix—ovarian cancer	0.00138	0.0119	CbGeAlD
Mirtazapine—HRH1—decidua—ovarian cancer	0.00134	0.0116	CbGeAlD
Mirtazapine—ADRA2A—decidua—ovarian cancer	0.00132	0.0114	CbGeAlD
Mirtazapine—HRH1—endometrium—ovarian cancer	0.00127	0.011	CbGeAlD
Mirtazapine—ADRA2A—endometrium—ovarian cancer	0.00125	0.0108	CbGeAlD
Mirtazapine—CYP2C8—female reproductive system—ovarian cancer	0.0012	0.0104	CbGeAlD
Mirtazapine—HTR2A—epithelium—ovarian cancer	0.00118	0.0102	CbGeAlD
Mirtazapine—SLC6A2—testis—ovarian cancer	0.00118	0.0102	CbGeAlD
Mirtazapine—ADRA2C—female gonad—ovarian cancer	0.00118	0.0102	CbGeAlD
Mirtazapine—ADRA2C—vagina—ovarian cancer	0.00117	0.0101	CbGeAlD
Mirtazapine—ADRA2A—gonad—ovarian cancer	0.00116	0.01	CbGeAlD
Mirtazapine—ADRA2A—uterus—ovarian cancer	0.00115	0.00996	CbGeAlD
Mirtazapine—HTR7—testis—ovarian cancer	0.00114	0.00985	CbGeAlD
Mirtazapine—CYP2C8—vagina—ovarian cancer	0.00109	0.00941	CbGeAlD
Mirtazapine—DRD2—testis—ovarian cancer	0.00108	0.00931	CbGeAlD
Mirtazapine—CYP2C9—female reproductive system—ovarian cancer	0.00107	0.00924	CbGeAlD
Mirtazapine—HRH1—female reproductive system—ovarian cancer	0.00105	0.00911	CbGeAlD
Mirtazapine—ADRA2C—testis—ovarian cancer	0.00105	0.00905	CbGeAlD
Mirtazapine—ADRA2A—female reproductive system—ovarian cancer	0.00103	0.00895	CbGeAlD
Mirtazapine—HTR2A—gonad—ovarian cancer	0.000985	0.00852	CbGeAlD
Mirtazapine—CYP2C8—testis—ovarian cancer	0.00097	0.0084	CbGeAlD
Mirtazapine—HTR2B—lymph node—ovarian cancer	0.000963	0.00834	CbGeAlD
Mirtazapine—HRH1—female gonad—ovarian cancer	0.000958	0.00829	CbGeAlD
Mirtazapine—HRH1—vagina—ovarian cancer	0.000952	0.00824	CbGeAlD
Mirtazapine—ADRA2A—female gonad—ovarian cancer	0.000941	0.00815	CbGeAlD
Mirtazapine—ADRA2A—vagina—ovarian cancer	0.000935	0.0081	CbGeAlD
Mirtazapine—HTR2A—female reproductive system—ovarian cancer	0.000879	0.00761	CbGeAlD
Mirtazapine—SLC6A2—lymph node—ovarian cancer	0.000856	0.00741	CbGeAlD
Mirtazapine—HRH1—testis—ovarian cancer	0.00085	0.00736	CbGeAlD
Mirtazapine—ADRA2A—testis—ovarian cancer	0.000835	0.00722	CbGeAlD
Mirtazapine—CYP3A4—female reproductive system—ovarian cancer	0.000814	0.00705	CbGeAlD
Mirtazapine—CYP2D6—female reproductive system—ovarian cancer	0.000801	0.00693	CbGeAlD
Mirtazapine—HTR2A—vagina—ovarian cancer	0.000795	0.00688	CbGeAlD
Mirtazapine—ADRA2C—lymph node—ovarian cancer	0.000758	0.00656	CbGeAlD
Mirtazapine—CYP2D6—female gonad—ovarian cancer	0.000729	0.00631	CbGeAlD
Mirtazapine—HTR2A—testis—ovarian cancer	0.00071	0.00614	CbGeAlD
Mirtazapine—CYP2D6—testis—ovarian cancer	0.000647	0.0056	CbGeAlD
Mirtazapine—HRH1—lymph node—ovarian cancer	0.000616	0.00533	CbGeAlD
Mirtazapine—ADRA2A—lymph node—ovarian cancer	0.000605	0.00524	CbGeAlD
Mirtazapine—Myalgia—Docetaxel—ovarian cancer	0.000338	0.000532	CcSEcCtD
Mirtazapine—Arthralgia—Docetaxel—ovarian cancer	0.000338	0.000532	CcSEcCtD
Mirtazapine—Chest pain—Docetaxel—ovarian cancer	0.000338	0.000532	CcSEcCtD
Mirtazapine—Pancytopenia—Doxorubicin—ovarian cancer	0.000338	0.000532	CcSEcCtD
Mirtazapine—Nausea—Vinorelbine—ovarian cancer	0.000338	0.000531	CcSEcCtD
Mirtazapine—Dyspepsia—Paclitaxel—ovarian cancer	0.000336	0.00053	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000336	0.000528	CcSEcCtD
Mirtazapine—Stomatitis—Epirubicin—ovarian cancer	0.000334	0.000526	CcSEcCtD
Mirtazapine—Jaundice—Epirubicin—ovarian cancer	0.000334	0.000526	CcSEcCtD
Mirtazapine—Conjunctivitis—Epirubicin—ovarian cancer	0.000333	0.000524	CcSEcCtD
Mirtazapine—Urinary tract infection—Epirubicin—ovarian cancer	0.000333	0.000524	CcSEcCtD
Mirtazapine—Dysuria—Doxorubicin—ovarian cancer	0.000332	0.000523	CcSEcCtD
Mirtazapine—Neutropenia—Doxorubicin—ovarian cancer	0.000332	0.000523	CcSEcCtD
Mirtazapine—Decreased appetite—Paclitaxel—ovarian cancer	0.000332	0.000523	CcSEcCtD
Mirtazapine—Dry mouth—Docetaxel—ovarian cancer	0.00033	0.00052	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00033	0.000519	CcSEcCtD
Mirtazapine—Fatigue—Paclitaxel—ovarian cancer	0.00033	0.000519	CcSEcCtD
Mirtazapine—Sweating—Epirubicin—ovarian cancer	0.000328	0.000517	CcSEcCtD
Mirtazapine—Pollakiuria—Doxorubicin—ovarian cancer	0.000328	0.000517	CcSEcCtD
Mirtazapine—Constipation—Paclitaxel—ovarian cancer	0.000327	0.000515	CcSEcCtD
Mirtazapine—Pain—Paclitaxel—ovarian cancer	0.000327	0.000515	CcSEcCtD
Mirtazapine—Haematuria—Epirubicin—ovarian cancer	0.000327	0.000514	CcSEcCtD
Mirtazapine—Confusional state—Docetaxel—ovarian cancer	0.000327	0.000514	CcSEcCtD
Mirtazapine—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000325	0.000511	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000324	0.00051	CcSEcCtD
Mirtazapine—Oedema—Docetaxel—ovarian cancer	0.000324	0.00051	CcSEcCtD
Mirtazapine—Weight increased—Doxorubicin—ovarian cancer	0.000324	0.000509	CcSEcCtD
Mirtazapine—Epistaxis—Epirubicin—ovarian cancer	0.000323	0.000509	CcSEcCtD
Mirtazapine—Infection—Docetaxel—ovarian cancer	0.000322	0.000507	CcSEcCtD
Mirtazapine—Weight decreased—Doxorubicin—ovarian cancer	0.000322	0.000506	CcSEcCtD
Mirtazapine—Sinusitis—Epirubicin—ovarian cancer	0.000321	0.000506	CcSEcCtD
Mirtazapine—Agranulocytosis—Epirubicin—ovarian cancer	0.00032	0.000503	CcSEcCtD
Mirtazapine—Pneumonia—Doxorubicin—ovarian cancer	0.000319	0.000502	CcSEcCtD
Mirtazapine—Shock—Docetaxel—ovarian cancer	0.000319	0.000502	CcSEcCtD
Mirtazapine—Nervous system disorder—Docetaxel—ovarian cancer	0.000318	0.0005	CcSEcCtD
Mirtazapine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000317	0.000499	CcSEcCtD
Mirtazapine—Drowsiness—Doxorubicin—ovarian cancer	0.000317	0.000499	CcSEcCtD
Mirtazapine—Tachycardia—Docetaxel—ovarian cancer	0.000316	0.000498	CcSEcCtD
Mirtazapine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000315	0.000496	CcSEcCtD
Mirtazapine—Skin disorder—Docetaxel—ovarian cancer	0.000315	0.000495	CcSEcCtD
Mirtazapine—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000314	0.000495	CcSEcCtD
Mirtazapine—Bradycardia—Epirubicin—ovarian cancer	0.000313	0.000493	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000313	0.000492	CcSEcCtD
Mirtazapine—Stomatitis—Doxorubicin—ovarian cancer	0.000309	0.000486	CcSEcCtD
Mirtazapine—Jaundice—Doxorubicin—ovarian cancer	0.000309	0.000486	CcSEcCtD
Mirtazapine—Anorexia—Docetaxel—ovarian cancer	0.000309	0.000486	CcSEcCtD
Mirtazapine—Rhinitis—Epirubicin—ovarian cancer	0.000308	0.000485	CcSEcCtD
Mirtazapine—Urinary tract infection—Doxorubicin—ovarian cancer	0.000308	0.000485	CcSEcCtD
Mirtazapine—Conjunctivitis—Doxorubicin—ovarian cancer	0.000308	0.000485	CcSEcCtD
Mirtazapine—Hepatitis—Epirubicin—ovarian cancer	0.000308	0.000484	CcSEcCtD
Mirtazapine—Hypoaesthesia—Epirubicin—ovarian cancer	0.000306	0.000482	CcSEcCtD
Mirtazapine—Pharyngitis—Epirubicin—ovarian cancer	0.000305	0.000481	CcSEcCtD
Mirtazapine—Sweating—Doxorubicin—ovarian cancer	0.000304	0.000478	CcSEcCtD
Mirtazapine—Urinary tract disorder—Epirubicin—ovarian cancer	0.000304	0.000478	CcSEcCtD
Mirtazapine—Urticaria—Paclitaxel—ovarian cancer	0.000304	0.000478	CcSEcCtD
Mirtazapine—Oedema peripheral—Epirubicin—ovarian cancer	0.000303	0.000477	CcSEcCtD
Mirtazapine—Hypotension—Docetaxel—ovarian cancer	0.000303	0.000477	CcSEcCtD
Mirtazapine—Haematuria—Doxorubicin—ovarian cancer	0.000302	0.000476	CcSEcCtD
Mirtazapine—Abdominal pain—Paclitaxel—ovarian cancer	0.000302	0.000476	CcSEcCtD
Mirtazapine—Body temperature increased—Paclitaxel—ovarian cancer	0.000302	0.000476	CcSEcCtD
Mirtazapine—Urethral disorder—Epirubicin—ovarian cancer	0.000301	0.000475	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.0003	0.000472	CcSEcCtD
Mirtazapine—Epistaxis—Doxorubicin—ovarian cancer	0.000299	0.000471	CcSEcCtD
Mirtazapine—Sinusitis—Doxorubicin—ovarian cancer	0.000297	0.000468	CcSEcCtD
Mirtazapine—Agranulocytosis—Doxorubicin—ovarian cancer	0.000296	0.000466	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000295	0.000465	CcSEcCtD
Mirtazapine—Insomnia—Docetaxel—ovarian cancer	0.000293	0.000461	CcSEcCtD
Mirtazapine—Paraesthesia—Docetaxel—ovarian cancer	0.000291	0.000458	CcSEcCtD
Mirtazapine—Erythema multiforme—Epirubicin—ovarian cancer	0.000291	0.000458	CcSEcCtD
Mirtazapine—Bradycardia—Doxorubicin—ovarian cancer	0.00029	0.000456	CcSEcCtD
Mirtazapine—Dyspnoea—Docetaxel—ovarian cancer	0.000289	0.000455	CcSEcCtD
Mirtazapine—Somnolence—Docetaxel—ovarian cancer	0.000288	0.000453	CcSEcCtD
Mirtazapine—Eye disorder—Epirubicin—ovarian cancer	0.000287	0.000452	CcSEcCtD
Mirtazapine—Tinnitus—Epirubicin—ovarian cancer	0.000287	0.000451	CcSEcCtD
Mirtazapine—Cardiac disorder—Epirubicin—ovarian cancer	0.000285	0.000449	CcSEcCtD
Mirtazapine—Rhinitis—Doxorubicin—ovarian cancer	0.000285	0.000449	CcSEcCtD
Mirtazapine—Dyspepsia—Docetaxel—ovarian cancer	0.000285	0.000449	CcSEcCtD
Mirtazapine—Hepatitis—Doxorubicin—ovarian cancer	0.000285	0.000448	CcSEcCtD
Mirtazapine—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000283	0.000446	CcSEcCtD
Mirtazapine—Pharyngitis—Doxorubicin—ovarian cancer	0.000282	0.000445	CcSEcCtD
Mirtazapine—Decreased appetite—Docetaxel—ovarian cancer	0.000282	0.000443	CcSEcCtD
Mirtazapine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000282	0.000443	CcSEcCtD
Mirtazapine—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000281	0.000442	CcSEcCtD
Mirtazapine—Oedema peripheral—Doxorubicin—ovarian cancer	0.00028	0.000441	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00028	0.00044	CcSEcCtD
Mirtazapine—Fatigue—Docetaxel—ovarian cancer	0.000279	0.00044	CcSEcCtD
Mirtazapine—Angiopathy—Epirubicin—ovarian cancer	0.000279	0.000439	CcSEcCtD
Mirtazapine—Urethral disorder—Doxorubicin—ovarian cancer	0.000279	0.000439	CcSEcCtD
Mirtazapine—Pain—Docetaxel—ovarian cancer	0.000277	0.000436	CcSEcCtD
Mirtazapine—Constipation—Docetaxel—ovarian cancer	0.000277	0.000436	CcSEcCtD
Mirtazapine—Chills—Epirubicin—ovarian cancer	0.000276	0.000434	CcSEcCtD
Mirtazapine—Arrhythmia—Epirubicin—ovarian cancer	0.000275	0.000433	CcSEcCtD
Mirtazapine—Asthenia—Paclitaxel—ovarian cancer	0.000274	0.000432	CcSEcCtD
Mirtazapine—Alopecia—Epirubicin—ovarian cancer	0.000272	0.000428	CcSEcCtD
Mirtazapine—Pruritus—Paclitaxel—ovarian cancer	0.00027	0.000426	CcSEcCtD
Mirtazapine—Mental disorder—Epirubicin—ovarian cancer	0.000269	0.000424	CcSEcCtD
Mirtazapine—Erythema multiforme—Doxorubicin—ovarian cancer	0.000269	0.000424	CcSEcCtD
Mirtazapine—Malnutrition—Epirubicin—ovarian cancer	0.000268	0.000421	CcSEcCtD
Mirtazapine—Feeling abnormal—Docetaxel—ovarian cancer	0.000267	0.00042	CcSEcCtD
Mirtazapine—Eye disorder—Doxorubicin—ovarian cancer	0.000266	0.000419	CcSEcCtD
Mirtazapine—Tinnitus—Doxorubicin—ovarian cancer	0.000265	0.000418	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000265	0.000417	CcSEcCtD
Mirtazapine—Cardiac disorder—Doxorubicin—ovarian cancer	0.000264	0.000416	CcSEcCtD
Mirtazapine—Flatulence—Epirubicin—ovarian cancer	0.000264	0.000415	CcSEcCtD
Mirtazapine—Tension—Epirubicin—ovarian cancer	0.000263	0.000414	CcSEcCtD
Mirtazapine—Dysgeusia—Epirubicin—ovarian cancer	0.000262	0.000413	CcSEcCtD
Mirtazapine—Diarrhoea—Paclitaxel—ovarian cancer	0.000262	0.000412	CcSEcCtD
Mirtazapine—Nervousness—Epirubicin—ovarian cancer	0.00026	0.000409	CcSEcCtD
Mirtazapine—Back pain—Epirubicin—ovarian cancer	0.000259	0.000408	CcSEcCtD
Mirtazapine—Angiopathy—Doxorubicin—ovarian cancer	0.000258	0.000406	CcSEcCtD
Mirtazapine—Abdominal pain—Docetaxel—ovarian cancer	0.000256	0.000403	CcSEcCtD
Mirtazapine—Body temperature increased—Docetaxel—ovarian cancer	0.000256	0.000403	CcSEcCtD
Mirtazapine—Chills—Doxorubicin—ovarian cancer	0.000255	0.000402	CcSEcCtD
Mirtazapine—Arrhythmia—Doxorubicin—ovarian cancer	0.000254	0.0004	CcSEcCtD
Mirtazapine—Dizziness—Paclitaxel—ovarian cancer	0.000253	0.000398	CcSEcCtD
Mirtazapine—Alopecia—Doxorubicin—ovarian cancer	0.000251	0.000396	CcSEcCtD
Mirtazapine—Mental disorder—Doxorubicin—ovarian cancer	0.000249	0.000392	CcSEcCtD
Mirtazapine—Ill-defined disorder—Epirubicin—ovarian cancer	0.000248	0.000391	CcSEcCtD
Mirtazapine—Malnutrition—Doxorubicin—ovarian cancer	0.000248	0.00039	CcSEcCtD
Mirtazapine—Anaemia—Epirubicin—ovarian cancer	0.000247	0.00039	CcSEcCtD
Mirtazapine—Agitation—Epirubicin—ovarian cancer	0.000246	0.000387	CcSEcCtD
Mirtazapine—Flatulence—Doxorubicin—ovarian cancer	0.000244	0.000384	CcSEcCtD
Mirtazapine—Tension—Doxorubicin—ovarian cancer	0.000243	0.000383	CcSEcCtD
Mirtazapine—Vomiting—Paclitaxel—ovarian cancer	0.000243	0.000383	CcSEcCtD
Mirtazapine—Dysgeusia—Doxorubicin—ovarian cancer	0.000243	0.000382	CcSEcCtD
Mirtazapine—Malaise—Epirubicin—ovarian cancer	0.000241	0.00038	CcSEcCtD
Mirtazapine—Rash—Paclitaxel—ovarian cancer	0.000241	0.000379	CcSEcCtD
Mirtazapine—Dermatitis—Paclitaxel—ovarian cancer	0.000241	0.000379	CcSEcCtD
Mirtazapine—Nervousness—Doxorubicin—ovarian cancer	0.000241	0.000379	CcSEcCtD
Mirtazapine—Vertigo—Epirubicin—ovarian cancer	0.000241	0.000379	CcSEcCtD
Mirtazapine—Syncope—Epirubicin—ovarian cancer	0.00024	0.000378	CcSEcCtD
Mirtazapine—Leukopenia—Epirubicin—ovarian cancer	0.00024	0.000377	CcSEcCtD
Mirtazapine—Back pain—Doxorubicin—ovarian cancer	0.00024	0.000377	CcSEcCtD
Mirtazapine—Headache—Paclitaxel—ovarian cancer	0.000239	0.000377	CcSEcCtD
Mirtazapine—Hypersensitivity—Docetaxel—ovarian cancer	0.000239	0.000376	CcSEcCtD
Mirtazapine—Palpitations—Epirubicin—ovarian cancer	0.000237	0.000372	CcSEcCtD
Mirtazapine—Loss of consciousness—Epirubicin—ovarian cancer	0.000235	0.00037	CcSEcCtD
Mirtazapine—Cough—Epirubicin—ovarian cancer	0.000234	0.000368	CcSEcCtD
Mirtazapine—Asthenia—Docetaxel—ovarian cancer	0.000232	0.000366	CcSEcCtD
Mirtazapine—Convulsion—Epirubicin—ovarian cancer	0.000232	0.000365	CcSEcCtD
Mirtazapine—Hypertension—Epirubicin—ovarian cancer	0.000231	0.000364	CcSEcCtD
Mirtazapine—Ill-defined disorder—Doxorubicin—ovarian cancer	0.00023	0.000362	CcSEcCtD
Mirtazapine—Pruritus—Docetaxel—ovarian cancer	0.000229	0.000361	CcSEcCtD
Mirtazapine—Anaemia—Doxorubicin—ovarian cancer	0.000229	0.00036	CcSEcCtD
Mirtazapine—Chest pain—Epirubicin—ovarian cancer	0.000228	0.000359	CcSEcCtD
Mirtazapine—Arthralgia—Epirubicin—ovarian cancer	0.000228	0.000359	CcSEcCtD
Mirtazapine—Myalgia—Epirubicin—ovarian cancer	0.000228	0.000359	CcSEcCtD
Mirtazapine—Agitation—Doxorubicin—ovarian cancer	0.000228	0.000358	CcSEcCtD
Mirtazapine—Anxiety—Epirubicin—ovarian cancer	0.000227	0.000358	CcSEcCtD
Mirtazapine—Nausea—Paclitaxel—ovarian cancer	0.000227	0.000357	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000226	0.000356	CcSEcCtD
Mirtazapine—Discomfort—Epirubicin—ovarian cancer	0.000225	0.000355	CcSEcCtD
Mirtazapine—Malaise—Doxorubicin—ovarian cancer	0.000223	0.000352	CcSEcCtD
Mirtazapine—Dry mouth—Epirubicin—ovarian cancer	0.000223	0.000351	CcSEcCtD
Mirtazapine—Vertigo—Doxorubicin—ovarian cancer	0.000223	0.00035	CcSEcCtD
Mirtazapine—Syncope—Doxorubicin—ovarian cancer	0.000222	0.00035	CcSEcCtD
Mirtazapine—Leukopenia—Doxorubicin—ovarian cancer	0.000222	0.000349	CcSEcCtD
Mirtazapine—Diarrhoea—Docetaxel—ovarian cancer	0.000222	0.000349	CcSEcCtD
Mirtazapine—Confusional state—Epirubicin—ovarian cancer	0.00022	0.000347	CcSEcCtD
Mirtazapine—Palpitations—Doxorubicin—ovarian cancer	0.000219	0.000345	CcSEcCtD
Mirtazapine—Oedema—Epirubicin—ovarian cancer	0.000219	0.000344	CcSEcCtD
Mirtazapine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000218	0.000343	CcSEcCtD
Mirtazapine—Infection—Epirubicin—ovarian cancer	0.000217	0.000342	CcSEcCtD
Mirtazapine—Cough—Doxorubicin—ovarian cancer	0.000216	0.00034	CcSEcCtD
Mirtazapine—Shock—Epirubicin—ovarian cancer	0.000215	0.000338	CcSEcCtD
Mirtazapine—Convulsion—Doxorubicin—ovarian cancer	0.000215	0.000338	CcSEcCtD
Mirtazapine—Nervous system disorder—Epirubicin—ovarian cancer	0.000214	0.000337	CcSEcCtD
Mirtazapine—Dizziness—Docetaxel—ovarian cancer	0.000214	0.000337	CcSEcCtD
Mirtazapine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000214	0.000337	CcSEcCtD
Mirtazapine—Hypertension—Doxorubicin—ovarian cancer	0.000214	0.000337	CcSEcCtD
Mirtazapine—Tachycardia—Epirubicin—ovarian cancer	0.000213	0.000336	CcSEcCtD
Mirtazapine—Skin disorder—Epirubicin—ovarian cancer	0.000212	0.000334	CcSEcCtD
Mirtazapine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000211	0.000333	CcSEcCtD
Mirtazapine—Myalgia—Doxorubicin—ovarian cancer	0.000211	0.000332	CcSEcCtD
Mirtazapine—Chest pain—Doxorubicin—ovarian cancer	0.000211	0.000332	CcSEcCtD
Mirtazapine—Arthralgia—Doxorubicin—ovarian cancer	0.000211	0.000332	CcSEcCtD
Mirtazapine—Anxiety—Doxorubicin—ovarian cancer	0.00021	0.000331	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000209	0.00033	CcSEcCtD
Mirtazapine—Discomfort—Doxorubicin—ovarian cancer	0.000208	0.000328	CcSEcCtD
Mirtazapine—Anorexia—Epirubicin—ovarian cancer	0.000208	0.000328	CcSEcCtD
Mirtazapine—Dry mouth—Doxorubicin—ovarian cancer	0.000206	0.000325	CcSEcCtD
Mirtazapine—Vomiting—Docetaxel—ovarian cancer	0.000206	0.000324	CcSEcCtD
Mirtazapine—Rash—Docetaxel—ovarian cancer	0.000204	0.000322	CcSEcCtD
Mirtazapine—Hypotension—Epirubicin—ovarian cancer	0.000204	0.000321	CcSEcCtD
Mirtazapine—Dermatitis—Docetaxel—ovarian cancer	0.000204	0.000321	CcSEcCtD
Mirtazapine—Confusional state—Doxorubicin—ovarian cancer	0.000204	0.000321	CcSEcCtD
Mirtazapine—Headache—Docetaxel—ovarian cancer	0.000203	0.000319	CcSEcCtD
Mirtazapine—Oedema—Doxorubicin—ovarian cancer	0.000202	0.000318	CcSEcCtD
Mirtazapine—Infection—Doxorubicin—ovarian cancer	0.000201	0.000316	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000199	0.000313	CcSEcCtD
Mirtazapine—Shock—Doxorubicin—ovarian cancer	0.000199	0.000313	CcSEcCtD
Mirtazapine—Nervous system disorder—Doxorubicin—ovarian cancer	0.000198	0.000312	CcSEcCtD
Mirtazapine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000198	0.000312	CcSEcCtD
Mirtazapine—Insomnia—Epirubicin—ovarian cancer	0.000198	0.000311	CcSEcCtD
Mirtazapine—Tachycardia—Doxorubicin—ovarian cancer	0.000197	0.000311	CcSEcCtD
Mirtazapine—Skin disorder—Doxorubicin—ovarian cancer	0.000196	0.000309	CcSEcCtD
Mirtazapine—Paraesthesia—Epirubicin—ovarian cancer	0.000196	0.000309	CcSEcCtD
Mirtazapine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000195	0.000308	CcSEcCtD
Mirtazapine—Dyspnoea—Epirubicin—ovarian cancer	0.000195	0.000307	CcSEcCtD
Mirtazapine—Somnolence—Epirubicin—ovarian cancer	0.000194	0.000306	CcSEcCtD
Mirtazapine—Anorexia—Doxorubicin—ovarian cancer	0.000193	0.000303	CcSEcCtD
Mirtazapine—Nausea—Docetaxel—ovarian cancer	0.000192	0.000303	CcSEcCtD
Mirtazapine—Dyspepsia—Epirubicin—ovarian cancer	0.000192	0.000303	CcSEcCtD
Mirtazapine—Decreased appetite—Epirubicin—ovarian cancer	0.00019	0.000299	CcSEcCtD
Mirtazapine—Hypotension—Doxorubicin—ovarian cancer	0.000189	0.000297	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000189	0.000297	CcSEcCtD
Mirtazapine—Fatigue—Epirubicin—ovarian cancer	0.000188	0.000297	CcSEcCtD
Mirtazapine—Constipation—Epirubicin—ovarian cancer	0.000187	0.000294	CcSEcCtD
Mirtazapine—Pain—Epirubicin—ovarian cancer	0.000187	0.000294	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000184	0.00029	CcSEcCtD
Mirtazapine—Insomnia—Doxorubicin—ovarian cancer	0.000183	0.000288	CcSEcCtD
Mirtazapine—Paraesthesia—Doxorubicin—ovarian cancer	0.000182	0.000286	CcSEcCtD
Mirtazapine—Dyspnoea—Doxorubicin—ovarian cancer	0.00018	0.000284	CcSEcCtD
Mirtazapine—Feeling abnormal—Epirubicin—ovarian cancer	0.00018	0.000283	CcSEcCtD
Mirtazapine—Somnolence—Doxorubicin—ovarian cancer	0.00018	0.000283	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000179	0.000281	CcSEcCtD
Mirtazapine—Dyspepsia—Doxorubicin—ovarian cancer	0.000178	0.00028	CcSEcCtD
Mirtazapine—Decreased appetite—Doxorubicin—ovarian cancer	0.000176	0.000277	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000175	0.000275	CcSEcCtD
Mirtazapine—Fatigue—Doxorubicin—ovarian cancer	0.000174	0.000274	CcSEcCtD
Mirtazapine—Urticaria—Epirubicin—ovarian cancer	0.000174	0.000273	CcSEcCtD
Mirtazapine—Pain—Doxorubicin—ovarian cancer	0.000173	0.000272	CcSEcCtD
Mirtazapine—Constipation—Doxorubicin—ovarian cancer	0.000173	0.000272	CcSEcCtD
Mirtazapine—Abdominal pain—Epirubicin—ovarian cancer	0.000173	0.000272	CcSEcCtD
Mirtazapine—Body temperature increased—Epirubicin—ovarian cancer	0.000173	0.000272	CcSEcCtD
Mirtazapine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000167	0.000262	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000165	0.00026	CcSEcCtD
Mirtazapine—Hypersensitivity—Epirubicin—ovarian cancer	0.000161	0.000253	CcSEcCtD
Mirtazapine—Urticaria—Doxorubicin—ovarian cancer	0.000161	0.000253	CcSEcCtD
Mirtazapine—Abdominal pain—Doxorubicin—ovarian cancer	0.00016	0.000252	CcSEcCtD
Mirtazapine—Body temperature increased—Doxorubicin—ovarian cancer	0.00016	0.000252	CcSEcCtD
Mirtazapine—Asthenia—Epirubicin—ovarian cancer	0.000157	0.000247	CcSEcCtD
Mirtazapine—Pruritus—Epirubicin—ovarian cancer	0.000155	0.000243	CcSEcCtD
Mirtazapine—Diarrhoea—Epirubicin—ovarian cancer	0.00015	0.000235	CcSEcCtD
Mirtazapine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000149	0.000234	CcSEcCtD
Mirtazapine—Asthenia—Doxorubicin—ovarian cancer	0.000145	0.000228	CcSEcCtD
Mirtazapine—Dizziness—Epirubicin—ovarian cancer	0.000144	0.000227	CcSEcCtD
Mirtazapine—Pruritus—Doxorubicin—ovarian cancer	0.000143	0.000225	CcSEcCtD
Mirtazapine—Vomiting—Epirubicin—ovarian cancer	0.000139	0.000219	CcSEcCtD
Mirtazapine—Diarrhoea—Doxorubicin—ovarian cancer	0.000138	0.000218	CcSEcCtD
Mirtazapine—Rash—Epirubicin—ovarian cancer	0.000138	0.000217	CcSEcCtD
Mirtazapine—Dermatitis—Epirubicin—ovarian cancer	0.000138	0.000217	CcSEcCtD
Mirtazapine—Headache—Epirubicin—ovarian cancer	0.000137	0.000215	CcSEcCtD
Mirtazapine—Dizziness—Doxorubicin—ovarian cancer	0.000134	0.00021	CcSEcCtD
Mirtazapine—Nausea—Epirubicin—ovarian cancer	0.00013	0.000204	CcSEcCtD
Mirtazapine—Vomiting—Doxorubicin—ovarian cancer	0.000129	0.000202	CcSEcCtD
Mirtazapine—Rash—Doxorubicin—ovarian cancer	0.000127	0.000201	CcSEcCtD
Mirtazapine—Dermatitis—Doxorubicin—ovarian cancer	0.000127	0.0002	CcSEcCtD
Mirtazapine—Headache—Doxorubicin—ovarian cancer	0.000127	0.000199	CcSEcCtD
Mirtazapine—Nausea—Doxorubicin—ovarian cancer	0.00012	0.000189	CcSEcCtD
Mirtazapine—ADRA1A—Signaling Pathways—CXCL8—ovarian cancer	1.04e-05	7.91e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PTEN—ovarian cancer	1.04e-05	7.91e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—PIK3CA—ovarian cancer	1.04e-05	7.89e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CDKN1B—ovarian cancer	1.04e-05	7.89e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CDKN1B—ovarian cancer	1.04e-05	7.87e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—TP53—ovarian cancer	1.04e-05	7.87e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—STAT3—ovarian cancer	1.04e-05	7.86e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—HRAS—ovarian cancer	1.04e-05	7.86e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CASP3—ovarian cancer	1.04e-05	7.86e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL2—ovarian cancer	1.03e-05	7.85e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—MAPK1—ovarian cancer	1.03e-05	7.85e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—NRAS—ovarian cancer	1.03e-05	7.84e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—EGFR—ovarian cancer	1.03e-05	7.84e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—IL6—ovarian cancer	1.03e-05	7.81e-05	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—AKT1—ovarian cancer	1.03e-05	7.81e-05	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—AKT1—ovarian cancer	1.03e-05	7.79e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CG—ovarian cancer	1.03e-05	7.78e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—VEGFA—ovarian cancer	1.02e-05	7.77e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—ERBB2—ovarian cancer	1.02e-05	7.75e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—TP53—ovarian cancer	1.02e-05	7.75e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CASP3—ovarian cancer	1.02e-05	7.73e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CDKN1B—ovarian cancer	1.02e-05	7.73e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL2—ovarian cancer	1.02e-05	7.72e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CASP3—ovarian cancer	1.02e-05	7.72e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CG—ovarian cancer	1.02e-05	7.71e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL2—ovarian cancer	1.02e-05	7.71e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—STAT3—ovarian cancer	1.01e-05	7.69e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—IL6—ovarian cancer	1.01e-05	7.68e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—NRAS—ovarian cancer	1.01e-05	7.67e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—IL6—ovarian cancer	1.01e-05	7.67e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—PIK3CA—ovarian cancer	1.01e-05	7.66e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CCND1—ovarian cancer	1.01e-05	7.65e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MTOR—ovarian cancer	1.01e-05	7.65e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PIK3CB—ovarian cancer	1.01e-05	7.65e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—AKT1—ovarian cancer	1.01e-05	7.64e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	1e-05	7.6e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—VEGFA—ovarian cancer	1e-05	7.6e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CTNNB1—ovarian cancer	9.98e-06	7.58e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CASP3—ovarian cancer	9.98e-06	7.57e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL2—ovarian cancer	9.96e-06	7.56e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—VEGFA—ovarian cancer	9.96e-06	7.56e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CCND1—ovarian cancer	9.92e-06	7.53e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—HRAS—ovarian cancer	9.92e-06	7.53e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—IL6—ovarian cancer	9.91e-06	7.52e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—STAT3—ovarian cancer	9.91e-06	7.52e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MAPK3—ovarian cancer	9.9e-06	7.51e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CCND1—ovarian cancer	9.9e-06	7.51e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—NRAS—ovarian cancer	9.89e-06	7.5e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—STAT3—ovarian cancer	9.86e-06	7.48e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—NRAS—ovarian cancer	9.84e-06	7.47e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CTNNB1—ovarian cancer	9.82e-06	7.45e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CTNNB1—ovarian cancer	9.8e-06	7.44e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MMP9—ovarian cancer	9.79e-06	7.43e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TP53—ovarian cancer	9.77e-06	7.41e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—KRAS—ovarian cancer	9.76e-06	7.41e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—HRAS—ovarian cancer	9.76e-06	7.41e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PTEN—ovarian cancer	9.73e-06	7.38e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CCND1—ovarian cancer	9.71e-06	7.37e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CXCL8—ovarian cancer	9.69e-06	7.35e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—VEGFA—ovarian cancer	9.69e-06	7.35e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MAPK3—ovarian cancer	9.68e-06	7.35e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—PIK3CA—ovarian cancer	9.64e-06	7.32e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MMP9—ovarian cancer	9.63e-06	7.31e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MYC—ovarian cancer	9.63e-06	7.31e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—HRAS—ovarian cancer	9.62e-06	7.3e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CTNNB1—ovarian cancer	9.62e-06	7.3e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MMP9—ovarian cancer	9.61e-06	7.29e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—STAT3—ovarian cancer	9.59e-06	7.28e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PTEN—ovarian cancer	9.57e-06	7.27e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PIK3CB—ovarian cancer	9.57e-06	7.26e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—NRAS—ovarian cancer	9.57e-06	7.26e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PTEN—ovarian cancer	9.55e-06	7.25e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—CAV1—ovarian cancer	9.53e-06	7.24e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—AKT1—ovarian cancer	9.49e-06	7.2e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—IL6—ovarian cancer	9.49e-06	7.2e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MAPK3—ovarian cancer	9.47e-06	7.19e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CDKN1B—ovarian cancer	9.46e-06	7.18e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MMP9—ovarian cancer	9.43e-06	7.16e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MAPK3—ovarian cancer	9.42e-06	7.15e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MAPK1—ovarian cancer	9.42e-06	7.15e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MYC—ovarian cancer	9.42e-06	7.15e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—EGFR—ovarian cancer	9.42e-06	7.15e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PTEN—ovarian cancer	9.37e-06	7.11e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—AKT1—ovarian cancer	9.36e-06	7.1e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—HRAS—ovarian cancer	9.34e-06	7.09e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—IL6—ovarian cancer	9.34e-06	7.09e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—AKT1—ovarian cancer	9.34e-06	7.09e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TP53—ovarian cancer	9.33e-06	7.08e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—AKT1—ovarian cancer	9.32e-06	7.07e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ABCB1—ovarian cancer	9.3e-06	7.06e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CASP3—ovarian cancer	9.27e-06	7.04e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL2—ovarian cancer	9.26e-06	7.03e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MAPK1—ovarian cancer	9.21e-06	6.99e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—EGFR—ovarian cancer	9.21e-06	6.99e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—IL6—ovarian cancer	9.21e-06	6.99e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MYC—ovarian cancer	9.21e-06	6.99e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MAPK3—ovarian cancer	9.16e-06	6.95e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MYC—ovarian cancer	9.16e-06	6.95e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—AKT1—ovarian cancer	9.15e-06	6.94e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—TYMS—ovarian cancer	9.13e-06	6.93e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	9.11e-06	6.91e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—PIK3CA—ovarian cancer	9.05e-06	6.87e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCND1—ovarian cancer	9.02e-06	6.85e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CD—ovarian cancer	9.01e-06	6.84e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MAPK1—ovarian cancer	9.01e-06	6.84e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—EGFR—ovarian cancer	9.01e-06	6.84e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—PIK3CA—ovarian cancer	8.97e-06	6.81e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MAPK1—ovarian cancer	8.96e-06	6.8e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—EGFR—ovarian cancer	8.96e-06	6.8e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—IL6—ovarian cancer	8.94e-06	6.79e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CTNNB1—ovarian cancer	8.94e-06	6.78e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CD—ovarian cancer	8.93e-06	6.78e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—HRAS—ovarian cancer	8.92e-06	6.77e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MYC—ovarian cancer	8.91e-06	6.76e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—KRAS—ovarian cancer	8.9e-06	6.75e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—VEGFA—ovarian cancer	8.79e-06	6.67e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MMP9—ovarian cancer	8.76e-06	6.65e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—AKT1—ovarian cancer	8.75e-06	6.64e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MAPK1—ovarian cancer	8.72e-06	6.62e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—EGFR—ovarian cancer	8.72e-06	6.62e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PTEN—ovarian cancer	8.71e-06	6.61e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—KRAS—ovarian cancer	8.7e-06	6.6e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—STAT3—ovarian cancer	8.7e-06	6.6e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CG—ovarian cancer	8.68e-06	6.59e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—NRAS—ovarian cancer	8.68e-06	6.59e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TP53—ovarian cancer	8.68e-06	6.59e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—VEGFA—ovarian cancer	8.65e-06	6.56e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—VEGFA—ovarian cancer	8.63e-06	6.55e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—AKT1—ovarian cancer	8.62e-06	6.54e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—STAT3—ovarian cancer	8.56e-06	6.5e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—STAT3—ovarian cancer	8.54e-06	6.48e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—NRAS—ovarian cancer	8.54e-06	6.48e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—IL6—ovarian cancer	8.54e-06	6.48e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—NRAS—ovarian cancer	8.52e-06	6.47e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—KRAS—ovarian cancer	8.51e-06	6.46e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—AKT1—ovarian cancer	8.5e-06	6.45e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—VEGFA—ovarian cancer	8.47e-06	6.43e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—KRAS—ovarian cancer	8.47e-06	6.43e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—STAT3—ovarian cancer	8.38e-06	6.36e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—NRAS—ovarian cancer	8.36e-06	6.35e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MAPK3—ovarian cancer	8.31e-06	6.31e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—HRAS—ovarian cancer	8.3e-06	6.3e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PTEN—ovarian cancer	8.27e-06	6.27e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—AKT1—ovarian cancer	8.25e-06	6.26e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—KRAS—ovarian cancer	8.23e-06	6.25e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MAPK3—ovarian cancer	8.18e-06	6.21e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—PIK3CA—ovarian cancer	8.17e-06	6.2e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MAPK3—ovarian cancer	8.16e-06	6.19e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MYC—ovarian cancer	8.09e-06	6.14e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MAPK3—ovarian cancer	8.01e-06	6.08e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—PIK3CA—ovarian cancer	8e-06	6.07e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MYC—ovarian cancer	7.96e-06	6.04e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—IL6—ovarian cancer	7.94e-06	6.03e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MYC—ovarian cancer	7.94e-06	6.03e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MAPK1—ovarian cancer	7.91e-06	6e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—EGFR—ovarian cancer	7.91e-06	6e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TP53—ovarian cancer	7.91e-06	6e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—AKT1—ovarian cancer	7.88e-06	5.98e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—VEGFA—ovarian cancer	7.87e-06	5.97e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	7.86e-06	5.96e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—PIK3CA—ovarian cancer	7.82e-06	5.93e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MYC—ovarian cancer	7.79e-06	5.91e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—STAT3—ovarian cancer	7.79e-06	5.91e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CB—ovarian cancer	7.79e-06	5.91e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MAPK1—ovarian cancer	7.78e-06	5.91e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—EGFR—ovarian cancer	7.78e-06	5.91e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—PIK3CA—ovarian cancer	7.78e-06	5.9e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—NRAS—ovarian cancer	7.77e-06	5.9e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MAPK1—ovarian cancer	7.77e-06	5.89e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—EGFR—ovarian cancer	7.77e-06	5.89e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TP53—ovarian cancer	7.73e-06	5.87e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CD—ovarian cancer	7.63e-06	5.79e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MAPK1—ovarian cancer	7.62e-06	5.78e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—EGFR—ovarian cancer	7.62e-06	5.78e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—PIK3CA—ovarian cancer	7.57e-06	5.74e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TP53—ovarian cancer	7.56e-06	5.74e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—HRAS—ovarian cancer	7.56e-06	5.74e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TP53—ovarian cancer	7.52e-06	5.71e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—KRAS—ovarian cancer	7.47e-06	5.67e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MAPK3—ovarian cancer	7.44e-06	5.65e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—HRAS—ovarian cancer	7.4e-06	5.61e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—AKT1—ovarian cancer	7.39e-06	5.61e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CAV1—ovarian cancer	7.36e-06	5.58e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—KRAS—ovarian cancer	7.35e-06	5.58e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PIK3CA—ovarian cancer	7.35e-06	5.58e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—KRAS—ovarian cancer	7.34e-06	5.57e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—AKT1—ovarian cancer	7.33e-06	5.56e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TP53—ovarian cancer	7.32e-06	5.55e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MYC—ovarian cancer	7.24e-06	5.49e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IL6—ovarian cancer	7.24e-06	5.49e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—HRAS—ovarian cancer	7.23e-06	5.49e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—KRAS—ovarian cancer	7.2e-06	5.46e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—HRAS—ovarian cancer	7.2e-06	5.46e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MAPK1—ovarian cancer	7.08e-06	5.37e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IL6—ovarian cancer	7.08e-06	5.37e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—EGFR—ovarian cancer	7.08e-06	5.37e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—HRAS—ovarian cancer	7e-06	5.31e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IL6—ovarian cancer	6.92e-06	5.25e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IL6—ovarian cancer	6.89e-06	5.23e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PIK3CA—ovarian cancer	6.86e-06	5.21e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PTEN—ovarian cancer	6.79e-06	5.15e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PIK3CA—ovarian cancer	6.75e-06	5.13e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PIK3CA—ovarian cancer	6.74e-06	5.11e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PTEN—ovarian cancer	6.73e-06	5.11e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	6.7e-06	5.09e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL6—ovarian cancer	6.7e-06	5.08e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—KRAS—ovarian cancer	6.69e-06	5.08e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—AKT1—ovarian cancer	6.68e-06	5.07e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CB—ovarian cancer	6.65e-06	5.05e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TP53—ovarian cancer	6.64e-06	5.04e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PIK3CA—ovarian cancer	6.61e-06	5.02e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TP53—ovarian cancer	6.53e-06	4.96e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—AKT1—ovarian cancer	6.53e-06	4.96e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TP53—ovarian cancer	6.52e-06	4.95e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TP53—ovarian cancer	6.4e-06	4.86e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—AKT1—ovarian cancer	6.39e-06	4.85e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—AKT1—ovarian cancer	6.35e-06	4.82e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—HRAS—ovarian cancer	6.35e-06	4.82e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—HRAS—ovarian cancer	6.25e-06	4.74e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—HRAS—ovarian cancer	6.24e-06	4.73e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—AKT1—ovarian cancer	6.18e-06	4.69e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PIK3CA—ovarian cancer	6.14e-06	4.66e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—HRAS—ovarian cancer	6.12e-06	4.64e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL6—ovarian cancer	6.08e-06	4.61e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—AKT1—ovarian cancer	6e-06	4.56e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL6—ovarian cancer	5.98e-06	4.54e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL6—ovarian cancer	5.97e-06	4.53e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TP53—ovarian cancer	5.94e-06	4.51e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	5.89e-06	4.47e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL6—ovarian cancer	5.86e-06	4.44e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PIK3CA—ovarian cancer	5.83e-06	4.43e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PTEN—ovarian cancer	5.75e-06	4.36e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—HRAS—ovarian cancer	5.69e-06	4.31e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—AKT1—ovarian cancer	5.61e-06	4.26e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—AKT1—ovarian cancer	5.52e-06	4.19e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—AKT1—ovarian cancer	5.51e-06	4.18e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL6—ovarian cancer	5.44e-06	4.13e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—AKT1—ovarian cancer	5.4e-06	4.1e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	5.14e-06	3.9e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—AKT1—ovarian cancer	5.02e-06	3.81e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	4.79e-06	3.63e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—AKT1—ovarian cancer	4.76e-06	3.62e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CA—ovarian cancer	4.75e-06	3.6e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PTEN—ovarian cancer	4.44e-06	3.37e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CA—ovarian cancer	4.06e-06	3.08e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—AKT1—ovarian cancer	3.91e-06	2.97e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—AKT1—ovarian cancer	3.88e-06	2.94e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—AKT1—ovarian cancer	3.31e-06	2.52e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	3.13e-06	2.38e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—AKT1—ovarian cancer	2.56e-06	1.94e-05	CbGpPWpGaD
